Aziyo biologics, inc. announces pricing of $11.2 million public offering of common stock

Silver spring, md., dec. 01, 2022 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo) (“aziyo”), a biologics company with a portfolio of regenerative products aimed at improving compatibility between medical devices and the patients they treat, today announced the pricing of its underwritten public offering of 2,350,000 shares of its common stock at a public offering price of $4.75 per share, before deducting underwriting discounts and commissions. aziyo also granted the underwriter a 30-day option to purchase up to an additional 352,500 shares of its common stock at the public offering price per share, less underwriting discounts and commissions. the gross proceeds from the public offering will be $11.2 million, before deducting underwriting discounts and commissions and offering expenses payable by aziyo and assuming no exercise of the underwriter's option to purchase additional shares of common stock. all shares in the offering are to be sold by aziyo.
AZYO Ratings Summary
AZYO Quant Ranking